NRI praises care given by MGMGH team to elderly parents
Ramachandran Saravanan, a non-resident Indian (NRI) solicitor in London, UK, has expressed his appreciation of the care given to his Tiruchi-based parents by the medical team at Mahatma Gandhi Memorial Government Hospital (MGMGH), in a letter addressed to Chief Minister M.K. Stalin and Deputy Chief Minister Udhayanidhi Stalin.
Mr. Saravanan's father, a retired Deputy Commissioner of Labour with the Government of Tamil Nadu, and mother, aged 85, are senior citizens living alone in Tiruchi. Mr. Saravanan, who shifted to the UK in 2010, had been monitoring his parents' health through regular video calls.
He sought assistance from the local authorities in April when he noticed that his mother seemed to be ailing. 'In response to my concerns, the team at Tiruchi Government Hospital, including Dean Dr. S. Kumaravel, [medical superintendent] Udhaya Aruna and [deputy superintendent] Arun Raj conducted a comprehensive medical assessment for both my parents and initiated a master check-up. My mother, who was suffering from an infected tooth, received prompt and effective treatment,' he wrote in his letter, shared with The Hindu, on Saturday.
On April 7, Mr. Saravanan alerted the authorities again fearing she had suffered a stroke. The MGMGH team diagnosed facial palsy and admitted her to the intermediate care unit (IMCU) for further observation and care. 'Despite initially being unable to speak, swallow, or drink, she made a remarkable recovery ,' said Mr. Saravanan.
'I cannot emphasise enough how deeply grateful I am for the dedicated care my parents received from the team at Tiruchi Government Hospital. Their professionalism, expertise, and compassion are truly commendable,' he wrote.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
4 hours ago
- The Hindu
Scientists uncover molecular clue to slow down reproductive aging
Researchers at the National Institute of Animal Biotechnology (NIAB) have made a significant discovery that could pave the way for new strategies to extend female fertility. Led by Prasad Rao from NIAB's Laboratory of Molecular Reproduction and Aging, the team has uncovered a molecular clue that appears to slow down reproductive aging. The scientific team, using both live mouse models and cultured goat ovaries, found that reducing the activity of a cellular protein called 'Cathepsin B' (Cat B) helps preserve the ovarian reserve. This ovarian reserve is the finite pool of egg cells (oocytes) that female mammals are born with. Unlike sperm, these crucial egg cells cannot be regenerated. The findings are important since, unlike sperm, oocytes cannot be regenerated. 'Over time, the quantity and quality of these eggs naturally decline due to factors like oxidative stress, inflammation and general cellular wear. This process accelerates with age. 'Cat B,' a protein-degrading enzyme, seems to be a key driver of this decline. By lowering its levels, we may be able to delay egg loss, effectively extending fertility naturally,' said The scientist team, which includes Aradhana Mohanty, Anjali Kumari, Lava Kumar S., Ajith Kumar, Pravin Birajdar, Rohit Beniwal, Mohd Athar and Kiran Kumar P., pointed out that the implications go far beyond the laboratory. It is because across India's rural heartlands and urban hospitals, fertility is quietly becoming a shared crisis. As both livestock and women age, their ability to reproduce declines, with significant biological and economic consequences, said researchers. In humans, fertility begins to decline in the early 30s, with a sharper drop in the 40s, reducing chances of conception and increasing the risk of miscarriage or chromosomal disorders. While assisted reproductive technologies like IVF provide options, they are often costly, invasive and less effective in older women. A safe, biological method to slow ovarian ageing could revolutionise fertility preservation for millions. For farmers, a simple intervention to extend reproductive lifespan of livestock could improve herd productivity, reduce stray cattle populations, and support the incomes of smallholder farmers who form the backbone of Indian agriculture. This is a rare moment where science serves both the farm and the family. From barns to birthing rooms, this discovery bridges animal science and human medicine, promising a future where age is no longer a barrier to reproduction, said researchers. For a country navigating the twin challenges of rural sustainability and reproductive health, the implications are profound and hopeful, said NIAB director G. Taru Sharma. The research results were published in the latest issue of 'Aging Cell'.
Time of India
5 hours ago
- Time of India
Sales of diabetes & cardiovascular drugs up 50% in Guj in two years
Ahmedabad: Gujarat is battling an uphill struggle with lifestyle diseases. Sales of drugs used to manage cardiovascular diseases and diabetes have shot up by at least 50% in the past two years, suggesting both a growing disease burden and increased patient compliance. According to data intelligence platform Pharmarack, the moving annual total (MAT) for cardiac therapy drugs stood at Rs 1,632 crore as of May 2025, marking a 44.4% rise from Rs 1,130 crore recorded in May 2023. The corresponding figure for anti-diabetic therapy rose even more sharply, increasing by 55.5% from Rs 688 crore to Rs 1,070 crore during the same period. MAT is a rolling calculation of sales value over the previous 12 months, and analysts say the consistent uptick highlights a worrying rise in non-communicable diseases driven by sedentary lifestyle, poor diets and mounting stress levels, particularly in urban areas. According to experts, while the surge in sales is partly due to higher detection and treatment adherence, it also reflects the underlying rise in incidence. Sheetal Sapale, vice-president-commercial, Pharmarack, said, "The rise in incidence is definitely seen, especially among the younger age group. People in their 30s and 40s are now being increasingly diagnosed with chronic conditions that were earlier associated with ageing populations. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Nagelpilz-Innovation: Dieses Lasergerät ist ein Wunder Heilratgeber Weiterlesen Undo Poor lifestyle is the key culprit here. Moreover, with more young people succumbing to cardiovascular diseases, the awareness has also grown substantially, because of which early diagnosis is taking place. Obesity is another key factor responsible for the higher incidence of diabetes as well as cardiac ailments." Increased awareness, early diagnosis and improved access to care have also contributed to the jump in drug consumption. Several doctors say that more patients are now opting for continuous medication to manage conditions proactively, rather than waiting for complications to arise. Doctors, however, warn that dietary habits also need to change. "The Indian diet is predominantly carbohydrate-heavy and deficient in protein as well as fibre. There is a rise in the consumption of processed foods which are easily available through quick-commerce apps as well as food aggregators. Obesity in children is becoming increasingly common because of processed and sugary food being consumed by them. These invitations to conditions like diabetes and hypertension and other cardiac ailments," said Dr Manoj Vithalani, a physician and medical expert. Environmental pollution is also a key factor responsible for poor heart health, according to Dr Vithalani. City-based physicians said that lifestyle related diseases and conditions are on rise steadily primarily due to sedentary lifestyle, excessive screen consumption, outside foods and lack of exercise. The most common symptoms – which are often overlapping – include hypertension, diabetes, and obesity, they added. Dr Ramesh Goyal, a senior endocrinologist with Apollo Hospitals, said that there has been a rise in awareness about Type 2 diabetes and thus there will be relatively more patients than 2023. "Two specific classes of medications - SGLT2 inhibitors and GLP-1 receptor agonists – are more acceptable by the practitioners and may have seen a rise in the overall mix. As diabetes is an overlapping condition, it is possible that the patients are also on other medications," he added.
The Hindu
5 hours ago
- The Hindu
Central Pollution Control Board to decide on future of flue gas desulphurisation units: Power Minister
The Union Ministry of Power will wait for the Central Pollution Control Board (CPCB) to decide on whether flue gas desulphurisation (FGD) units should be mandatory for all coal-fired thermal power plants, Union Power Minister Manohar Lal Khattar said in a response to a question from The Hindu at a press conference on Tuesday (June 10, 2025). On the June 4, The Hindu had reported on a meeting in April involving a high-powered committee of experts, chaired by the Principal Scientific Advisor, Ajay Sood. The group recommended that India do away with its decade-long policy of mandating equipment, including FGD units, in all coal-fired thermal power plant units (TPPs). While 92% of India's 600 TPPs, spread across about 180 coal plants, haven't yet installed FGD units, the recommendation exempts about 80% of them from installing such equipment. So far, the government has granted three extensions since 2017, the latest being in December 2024, for plants to comply by 2027-2030. FGDs are an additional piece of equipment required to be retro-fitted in TPPs to cut harmful sulphur dioxide emissions resulting from burning coal. Sulphur dioxide emissions can also hover in the atmosphere and form aerosols of sulphates that, on the one hand, can somewhat temper the heat from global warming, but also exacerbate particulate matter pollution and respiratory diseases. It is estimated that the current installation cost of such equipment is about ₹1 crore per megawatt (MW) of installed power capacity. 'Scientific institutions such as CSIR (Council of Scientific and Industrial Research), IIT (Indian Institute of Technology) Delhi have studied this. The sulphate aerosols from these coal plants aren't to the extent that they affect human is less than 5%. On the contrary, it is necessary that some of it remain in the atmosphere. If it is too less, it can increase warming,' Mr. Khattar said. 'That said, the CPCB is looking at this and hasn't come to a conclusion. We will implement anything only after examining their verdict. About 97,000 MW of power will be added, and implementing FGD means an additional expense of ₹97,000 crore. We have to consider this carefully. Neither should health be harmed, nor people face increased tariffs, nor warming increase. You must have read about the thousands of lives lost in Europe from heatwaves,' he added. As The Hindu had reported, the committee, according to the minutes of the meeting viewed by The Hindu, will 'recommend' to the Power and Environment Ministers that only power plants located in a 10 km radius of the National Capital Region, and cities with a population of over one million, are required to install FGD units. These are called Category A plants. There are 66 such plants, and only 14 of them have installed FGD units. All these plants are required to comply by 2027. Those in a 10-km radius of 'Critically Polluted Cities' or 'Non Attainment Cities', called Category B plants, would be eligible for exemption on a 'case by case' basis, upon a joint review by the Central Electricity Authority or the CPCB. There are 72 such plants, with only 4 having installed FGD units. These plants have a deadline of 2028. The remaining 462 plants come under Category C. Thirty-two of them have installed FGD units. These plants have a 2029 deadline. Over 600 units in categories A and B could be additionally exempted if they were 20 years and older. 'The key common point in these studies is that, fitment of FGDs in all TPPs in India is not necessary to comply with the NAAQ (National Ambient Air Quality) standards whose compliance is essential to safeguard public health. While all TPPs must comply with the December 2015 stack emission standards for PM pollution and freshwater consumption, the SO2 stack emission standards can be relaxed to ensure that they are in conformance with the NAAQ standards which are notified by CPCB, keeping in mind the human health and other aspects. This way, TPPs may be able to comply with these standards without fitting FGDs. Since the existing NAAQ standards (for ambient SO2) must be complied with, this change will not affect human health in India,' the committee had concluded.
